Cancer Research and Treatment

Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients

Mijia Wang, Zhendong Wei, Jixia Kong, Haidong Zhao

Diagnostic Pathology.2024;[Epub] CrossRef

Clinical implications of receptor conversions in breast cancer patients who have undergone neoadjuvant chemotherapy

Sudheer Vemuru, Jin Huang, Kathryn Colborn, YooJin Yoon, Victoria Huynh, Laura Leonard, Gretchen Ahrendt, Nicole Christian, Anosheh Afghahi, Lauren McLemore, Sharon Sams, Sarah Tevis

Breast Cancer Research and Treatment.2023; 200(2): 247. CrossRef

Inflammasomes in breast cancer: the ignition spark of progression and resistance?

Expert Reviews in Molecular Medicine.2023;[Epub] CrossRef

Prognostic impact of reduced HER2 protein expression in post-neoadjuvant therapy resection specimens: A single institution experience and review of the literature

Jan Paredes Mogica, Haiming Tang, Yuanxin Liang, Minghao Zhong, Pei Hui, Malini Harigopal, Uma Krishnamurti, Neal A. Fischbach, Haiying Zhan

Research Progress and Future Prospect of HER-2 Low Expression Breast Cancer

Advances in Clinical Medicine.2023; 13(10): 16593. CrossRef

Role and evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy: consensus statement

Elena Guerini-Rocco, Gerardo Botti, Maria Pia Foschini, Caterina Marchiò, Mauro Giuseppe Mastropasqua, Giuseppe Perrone, Elena Roz, Alfredo Santinelli, Isabella Sassi, Viviana Galimberti, Luca Gianni, Giuseppe Viale

Tumori Journal.2022; 108(3): 196. CrossRef

HER2 changes to positive after neoadjuvant chemotherapy in breast cancer: A case report and literature review

World Journal of Clinical Cases.2022; 10(1): 260. CrossRef

Alterations in Breast Cancer Biomarkers Following Neoadjuvant Therapy

Srivarshini Cherukupalli Mohan, Sarah Walcott-Sapp, Minna K. Lee, Marissa K. Srour, Sungjin Kim, Farin F. Amersi, Armando E. Giuliano, Alice P. Chung

Annals of Surgical Oncology.2021; 28(11): 5907. CrossRef

Biomarkers Changes after Neoadjuvant Chemotherapy in Breast Cancer: A Seven-Year Single Institution Experience

Saverio Coiro, Elisa Gasparini, Giuseppe Falco, Giacomo Santandrea, Moira Foroni, Giulia Besutti, Valentina Iotti, Roberto Di Cicilia, Monica Foroni, Simone Mele, Guglielmo Ferrari, Giancarlo Bisagni, Moira Ragazzi

Pathologic reporting practices for breast cancer specimens after neoadjuvant chemotherapy—a survey of pathologists in academic institutions across the United States

Sonali Lanjewar, Priyanka Patil, Susan Fineberg

Modern Pathology.2020; 33(1): 91. CrossRef

HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation

Soomin Ahn, Ji Won Woo, Kyoungyul Lee, So Yeon Park

Journal of Pathology and Translational Medicine.2020; 54(1): 34. CrossRef

Modeling Neoadjuvant chemotherapy resistance in vitro increased NRP‐1 and HER2 expression and converted MCF7 breast cancer subtype

British Journal of Pharmacology.2020; 177(9): 2024. CrossRef

Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy

Gi Won Shin, Young Mi Park, Tae Hyun Kim, Anbok Lee, Ha Young Park, Hye Kyoung Yoon, Young Jin Heo, Jin Wook Baek, Yoo Jin Lee

Journal of the Korean Society of Radiology.2020; 81(2): 428. CrossRef

A Six-Epithelial–Mesenchymal Transition Gene Signature May Predict Metastasis of Triple-Negative Breast Cancer

Li Yuan Wei, Xiao Jun Zhang, Li Wang, Li Na Hu, Xu Dong Zhang, Li Li, Jin Nan Gao

OncoTargets and Therapy.2020; Volume 13: 6497. CrossRef

Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes

Haoyu Wang, Jiejie Yao, Ying Zhu, Weiwei Zhan, Xiaosong Chen, Kunwei Shen

Cancer Medicine.2020; 9(17): 6173. CrossRef

Effect of neoadjuvant therapy on breast cancer biomarker profile

Laura Rey-Vargas, Juan Carlos Mejía-Henao, María Carolina Sanabria-Salas, Silvia J. Serrano-Gomez

Surrogate Molecular Classification of Invasive Breast Carcinoma: A Comparison Between Core Needle Biopsy and Surgical Excision, With and Without Neoadjuvant Therapy

Andrea Ambrosini-Spaltro, Elena Zunarelli, Stefania Bettelli, Massimo Lupi, Giuditta Bernardelli, Marina Milani, Guido Ficarra

Applied Immunohistochemistry & Molecular Morphology.2020; 28(7): 551. CrossRef

Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications

Emma Zattarin, Rita Leporati, Francesca Ligorio, Riccardo Lobefaro, Andrea Vingiani, Giancarlo Pruneri, Claudio Vernieri

Prediction of breast cancer molecular subtypes using radiomics signatures of synthetic mammography from digital breast tomosynthesis

Jinwoo Son, Si Eun Lee, Eun-Kyung Kim, Sungwon Kim

Prognostic value of receptor status conversion following neoadjuvant chemotherapy in breast cancer patients: a systematic review and meta-analysis

Chao Li, Hongwei Fan, Qian Xiang, Ling Xu, Zhuo Zhang, Qianxin Liu, Tongtong Zhang, Jinjie Ling, Ying Zhou, Xia Zhao, Yimin Cui

Breast Cancer Research and Treatment.2019; 178(3): 497. CrossRef

Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy

Xinyan Li, Mozhi Wang, Mengshen Wang, Xueting Yu, Jingyi Guo, Tie Sun, Litong Yao, Qiang Zhang, Yingying Xu

Journal of Breast Cancer.2019; 22(4): 497. CrossRef

Neutralization of BCL-2/XL Enhances the Cytotoxicity of T-DM1 In Vivo

Jason J. Zoeller, Aleksandr Vagodny, Krishan Taneja, Benjamin Y. Tan, Neil O'Brien, Dennis J. Slamon, Deepak Sampath, Joel D. Leverson, Roderick T. Bronson, Deborah A. Dillon, Joan S. Brugge

Molecular Cancer Therapeutics.2019; 18(6): 1115. CrossRef

Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer

Soomin Ahn, Hyun Jeong Kim, Milim Kim, Yul Ri Chung, Eunyoung Kang, Eun-Kyu Kim, Se Hyun Kim, Yu Jung Kim, Jee Hyun Kim, In Ah Kim, So Yeon Park

Cancer Research and Treatment.2018; 50(4): 1418. CrossRef

Impact of Neoadjuvant Chemotherapy on Breast Cancer Subtype: Does Subtype Change and, if so, How?

Lucy M. De La Cruz, Michael O. Harhay, Paul Zhang, Stacy Ugras

Annals of Surgical Oncology.2018; 25(12): 3535. CrossRef

Modern therapies and iatrogenic changes in breast pathology

Biomarkers of residual disease after neoadjuvant therapy for breast cancer

Frederique Penault-Llorca, Nina Radosevic-Robin

Nature Reviews Clinical Oncology.2016; 13(8): 487. CrossRef

CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype

Tuan Zea Tan, He Yang, Jieru Ye, Jeffrey Low, Mahesh Choolani, David Shao Peng Tan, Jean-Paul Thiery, Ruby Yun-Ju Huang